NCT02255266View on ClinicalTrials.gov

Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

CompletedOBSERVATIONAL

Enrollment

1,788

Participants

Timeline

Start Date

March 26, 2015

Primary Completion Date

November 16, 2015

Study Completion Date

November 16, 2015

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

liraglutide

No treatment given.

Trial Locations (1)

00144

Novo Nordisk Investigational Site, Rome

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT02255266 - Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice | Biotech Hunter | Biotech Hunter